Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

How digital health is making early type 1 diabetes screening easier

(BPT) - By Mariano Bendersky, Head of Digital Healthcare & Innovation, U.S. Autoimmune T1D at Sanofi

Sponsored by Sanofi

Healthcare (as we know it) is evolving to meet the needs of an increasingly digital world. Between telehealth adoption and people of all ages embracing "health from home" solutions, it's clear that new tools and resources are shifting how people look at, and manage, their care - expanding preventative care and wellness for communities with unmet needs.

Take the type 1 diabetes (T1D) space, as one example. Today, new and exciting advancements are working to reduce barriers, increase access, and expand optionality when it comes to early T1D autoantibody screening. And it couldn't come at a better time. While T1D screening helps people understand their risk of developing the disease before symptoms (and potentially serious complications) appear, many are unaware that screening exists. Perhaps even more troubling, some have difficulty accessing it.

Thanks to an influx of digital innovation in the existing screening landscape, this is all about to change. Below, take a look at how T1D screening access is transforming in the digital age.

Why T1D screening matters

According to the T1D Index, an estimated 1.6 million people in the U.S. are living with T1D - an autoimmune disease wherein the pancreas makes little to no insulin. The disease doesn't occur overnight; it develops in stages over time. That said, in Stages 1 and 2 of the T1D, there are often no visible signs or symptoms, making it difficult to spot early. As a result, many are forced to find out about their diagnosis in Stage 3, when potentially severe complications can arise.

Unfortunately, according to Global Pediatric Health, as many as four in 10 people don't know they have T1D until they are already in the hospital with life-threatening complications. What's more, a status report in Diabetes shows that up to 90% of people diagnosed with T1D have no family history of the disease. Experiencing a T1D diagnosis like this - in an urgent scenario and with little prior exposure to the disease - can understandably be overwhelming. In an instant, you're thrusted into a new reality that requires 24/7 disease management. For this reason and more, early detection of the disease is valuable because it can offer a precious window of time when individuals can learn more about how to prepare for life with T1D before symptoms arise.

Doctor in white lab coat working on a tablet in an officeCaption: Your information will be evaluated by a healthcare provider. Credit: Shutterstock


Modernizing T1D screening access

In an effort to complement currently available T1D screening options and bring this potentially life-saving process to the digital age, Screening Central was born. As the first telehealth-enabled, user-initiated platform to request T1D autoantibody screening, Screening Central offers a comprehensive and convenient solution to help with every step of T1D screening. Developed in collaboration with Sanofi, the platform breaks down the process into three steps.

  • Getting Started: To start, visit Screening Central and answer a short health history questionnaire.
  • Getting Evaluated for Testing: From there, your information will be evaluated by an independent healthcare provider, who will determine whether you are an appropriate candidate for screening. If confirmed, you can decide what your preferred screening method is, which could include talking to your doctor, getting tested at a lab, or participating in research trials.
  • Getting Your Results: After that, you will receive a phone call or arrange a televisit to discuss results or you can choose to have results shared directly with your doctor.
Smiling woman sitting on a couch looking at her phone.

Caption: Screening Central can help you learn more about T1D screening. Credit: Shutterstock

In 2025, no one should find out they have T1D in Stage 3 under potentially life-threatening circumstances. By leveraging end-to-end digital health innovation, Screening Central helps overcome existing barriers to screening and makes it easier than ever to put early T1D risk detection first.

As you can see, innovation is truly around every corner in the T1D space. Equipped with breakthrough advancements like Screening Central, now is the time to learn more about T1D and understand if screening is right for you. To learn more about Screening Central - and the other screening options available to you - visit Screen For Type 1.

Sanofi does not provide medical advice, diagnosis, or treatment - information is provided for educational purposes only. Your doctor is the best source of health information. Talk to your doctor if you have any questions about your health or treatment.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.